- Home
- / Rich Pharmaceuticals
Rich Pharmaceuticals
Stock Price
$0
2021-11-01
Market Capitalization
$941.9 K
2021-11-01
Revenue
$115 K
FY, 2018
Rich Pharmaceuticals Summary
Company Summary
- Overview
- Rich Pharmaceuticals is a biopharmaceutical company that is focused on the development of its lead product, RP-323 (12-O-tetradecanoylphorbol-13-acetate), for the treatment of acute myelogenous leukemia (AML) in refractory patients.
- Type
- Public
- Status
- Active
- HQ
- Beverly Hills, CA, US | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Beverly Hills, CA HQ
United States
9595 Wilshire Blvd #900
Rich Pharmaceuticals Financials
Summary Financials
- Revenue (FY, 2018)
- $115.0K
- Net income (FY, 2018)
- ($1.7M)
- Cash (FY, 2018)
- $6.2K
- EBIT (FY, 2018)
- ($1.3M)
- Enterprise value
- $1.8M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026